Neil Harris Cohen Chemomab Therapeutics Ltd. (CMMB) insider trading activity
Neil Harris Cohen is Director of Chemomab Therapeutics Ltd.. Currently has a direct ownership of 10,000 shares of CMMB, which is worth approximately $13,799. The most recent transaction as insider was on Nov 16, 2022, when has been sold 2,409 shares (American Depositary Shares) at a price of $2.0 per share, resulting in proceeds of $4,818. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
10K
0%
3M change
0%
12M change
Total Value Held
$13,799
Neil Harris Cohen Transaction History
NHC
Neil Harris Cohen
Director
Cambridge, MA